+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Glucosamine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Glucosamine Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
From
Ibuprofen Arginine API Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ibuprofen Arginine API Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 199 Pages
  • Global
From
Ketoprofen Gel Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ketoprofen Gel Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Piroxicam Patch Market - Global Forecast 2026-2032 - Product Thumbnail Image

Piroxicam Patch Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 188 Pages
  • Global
From
Axial Spondyloarthritis Market - Global Forecast 2026-2032 - Product Thumbnail Image

Axial Spondyloarthritis Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Anti-Rheumatics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Rheumatics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
Aspirin Market - Global Forecast 2026-2032 - Product Thumbnail Image

Aspirin Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 190 Pages
  • Global
From
Ketoprofen Lysine Salt Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ketoprofen Lysine Salt Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Hashimotos Disease Market Report 2026 - Product Thumbnail Image

Hashimotos Disease Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • October 2026
  • 139 Pages
  • Global
From
From
Lupus Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Lupus Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 260 Pages
  • Global
From
From
Endometriosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 191 Pages
  • Global
From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 265 Pages
  • Global
From
From
Eye Allergy Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Eye Allergy Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 190 Pages
  • Global
From
Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • October 2026
  • 279 Pages
  • Global
From
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more